Indexus Biomedical
Indexus Biomedical

Indexus Biomedical

press to zoom
Indexus Biomedical
Indexus Biomedical

Indexus Biomedical

press to zoom

press to zoom
Indexus Biomedical
Indexus Biomedical

Indexus Biomedical

press to zoom

Innovation for Global Health

Indexus products are currently not available for diagnostic use

Indexus Biomedical is pioneering the development of innovative hybrid (multifunctional) technologies and products designed to enable small decentralized laboratories to deliver expanded menu of advanced in-vitro diagnostic (IVD) tests closer to the patient's home, offering faster and accurate results at reduced costs. 

Small decentralized laboratories include laboratories associated with urgent care and primary care clinics, physicians' offices, small hospitals, rural clinics, certain mobile clinics, and all other small to medium sized independent laboratories.

Technologies
Innovations for Global Health!
Indexus has developed an IP portfolio of uniquely advantageous molecular dx, immuno assay, cellular analysis, and hematology analysis technologies that will work together on a single multifunction instrument. The portfolio includes instrumentation, reagents, and assay protocols.
Products
Bringing Advanced Testing to the Decentralized Primary Care Laboratory

Our flagship product, the Indexus-TriSense Dx  multifunction blood analysis system is a first of a kind instrument delivering molecular and immuno-diagnostic tests on a small, easy to use, and affordable POC platform that also performs routine hematology tests.

Test Menu

Molecular Dx Tests for Infectious Diseases

including HIV 1, 2 and O, Hepatitis A, B, C and E, Respiratory Virus (Flu A/B, COVID-19)  

 

Vector Borne Diseases, including Malaria and Dengue

CBC with extended 5-Part Differential

 

Immune System Monitoring Assay (CD4/CD8 count Count)

 

Future Tests (Menu Expansion) 

Hematological Malignancies (leukemia, lymphoma)

 

Cancer Biomarker Assays

Sepsis Tests

Cardiac Panel

Multiplexed Inflammatory Biomarker Assay 

Our global-health focused products will deliver significantly increased access to affordable high-quality diagnostic testing for patients in both the developing and the developed world.

Services
  • System Integration: Integrating and automating multiple third-party point of care devices into unified laboratory workflow systems.

  • Procurement: Providing support to healthcare providers and government agencies in product sourcing, evaluations, and procurement for emerging healthcare needs.

  • Market Research: Providing market research in in-vitro diagnostics industry. 

Support
 

Indexus Biomedical has received support from the following organizations for its technology and product development initiatives:

  NIH      
NC Department 
of Commerce
NC Small Business and
Technology Development Center
TESTIMONIAL

“The TriSense Dx system will revolutionize the way our diagnostic labs approach patient samples!”     

Dr. Naba Hazarika, MD

Head of  Microbiology Department

Gauhati Medical College Hospital

In-charge, NACO-HIV2 Reference Lab and WHO Measles Surveillance Lab India

“Multifunction blood testing system will offer an extremely innovative solution to the small to the medium sized hospitals, clinics and diagnostic laboratories” 

Thomas N. Denny, MPhil 

Professor of Medicine

Chief Operatig Officer, Duke CHAVI-ID (Center for HIV/AIDS Vaccine Immunology)

Duke University Medical School

Durham, NC USA  

“Indexus TriSense Dx will be a perfect addition to the instruments currently used in the fight against leukemia and other diseases, for which early detection vastly improves the chances of cure.”  

Dr. Philippa Sprinz, MD

Hasbro Children's Hospital, Rhode Island

Ex-Director of Pediatric Hematology and Oncology

Boston Medical Center,

Boston, MA USA 

CONTACT

Indexus Biomedical LLC

2 Davis Drive

Durham, NC 27709

Phone: 919-824-0419

Email: info@indexusbiomed.com

“For a great number of hospitals, clinics and laboratories in tier 2 and tier 3 cities in India this instrument
will fill a critical void in the diagnostic testing continuum”

Dr. Indrajit Kalita, MD, Director of Diagnostics Pathology Labs, International Hospital

Guwahati India